CooperCompanies to Present at the J.P. Morgan Healthcare Conference

SAN RAMON, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, today announced it will participate at the J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025. Al White, President and CEO, will represent the Company in a session scheduled to begin at 6:00 PM ET.

A live and archived webcast of this event, where applicable, will be available by accessing the CooperCompanies’ website at http://investor.coopercos.com.

About CooperCompanies

CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women’s health company dedicated to assisting women, babies and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies (“Cooper”) has a workforce of more than 16,000 with products sold in over 130 countries. For more information, please visit www.coopercos.com.

Contact:

Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
[email protected]

You May Also Be Interested In

• Prospect Capital Schedules Fiscal Year Earnings Release and Conference Call
• 2026 CIFTIS Transportation and Business Services Section Media Briefing Held in Beijing
• Autozi Internet Technology (Global) Ltd. (Nasdaq: AZI) Announces Receipt of US$30 Million Investment to Accelerate Strategic Growth